This Analyst Just Upgraded ResMed Stock. Here's Why. ResMed stock rallies on a bullish RBC Capital research note. Here’s why analyst Craig Wong-Pan raised his price target on RMD shares today. Barchart · Sep 15
Tyler Reddick reveals sleep apnea diagnosis The 23XI Racing NASCAR Cup star opens up on his struggles with sleep apnea, and announces a new partnership with Resmed to help others also suffering from the sleep disorder Motorsport · Aug 25
ResMed Stock: Analyst Estimates & Ratings Although ResMed has underperformed the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects. Barchart · Aug 25
CPAP machine maker posts record revenue but shares sink Resmed shares have fallen nearly five per cent after inflation took a toll on the sleep apnoea company's gross profit margin. AAP · Aug 7
FDA Gives Its Most Serious Recall Class to ResMed Astral Ventilators, but Patients Are Told Not to Stop Using Them FDA assigned a Class 1 recall to ResMed Astral 100 and 150 ventilators. Patients are told not to stop use. Here is the guidance. Medical Daily · Jul 31
FDA Issues Early Alert on ResMed Astral Ventilators as Replacement Parts Run Short FDA alerts patients that certain ResMed Astral 100 and 150 ventilators may stop therapy. Parts are limited. What families should do now. Medical Daily · Jul 31
ResMed's Q4 2026 Earnings: What to Expect ResMed is scheduled to post its fourth-quarter results soon, and analysts project a double-digit earnings growth. Barchart · Jul 9
Is ResMed Stock Underperforming the Dow? While ResMed has underperformed relative to the Dow over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects. Barchart · Jun 11
Do Wall Street Analysts Like ResMed Stock? ResMed continues to command steady Wall Street confidence despite recent stock pressure and a few bumps along the road. Barchart · May 25
Oura, Resmed partnership helps point out sleep health issues you didn't know you had Oura announced a Resmed partnership, seeking to help users identify potential signs of OSA throughout the night. Android Central · May 19
Snoring leader buys restless leg syndrome device maker Sleep apnoea company Resmed has acquired a California firm that makes a device for patients with restless leg syndrome, the third-biggest sleep disorder. AAP · May 1
I was sleeping 8 hours a night but waking up exhausted — until a doctor taught me 3 tricks for ‘switching off’ before bed I thought 8 hours of sleep was enough, but stress was ruining my rest and recovery each night. These 3 simple doctor-approved tips have finally restored my morning energy levels. Tom’s Guide · Mar 30
5 simple 'body clock hacks' that help you fall asleep fast and wake up with more energy Want to fall asleep fast or wake up less groggy? These five cues will let your body clock know if it's time to rise and shine or hit the hay. Tom’s Guide · Mar 14
Is ResMed Stock Underperforming the Nasdaq? ResMed has underperformed the Nasdaq over the past year, but analysts are cautiously optimistic about the stock’s prospects. Barchart · Mar 12
Tom’s Guide · Mar 11 Research shows 53% of us only sleep well 4 nights a week and anxiety is a leading cause — an expert explains how to sleep better every night and skip the 3 a.m. wake ups Resmed has found only one-third of adults claim to sleep well every night — Dr. Carlos Nunez explains expert rules for beating the odds and getting good sleep, night after night.
AAP · Jan 30 Ozempic-style drugs prove to be 'a tailwind' for Resmed Resmed has beaten expectations with $2 billion in second-quarter revenue and says weight loss drugs are actually boosting sales, rather than hurting them.
Barchart · Dec 8, 2025 Is ResMed Stock Underperforming the S&P 500? Though ResMed has lagged behind the S&P 500 Index over the past year, analysts are moderately optimistic about the stock’s prospects.
Barchart · Sep 15, 2025 How Is ResMed's Stock Performance Compared to Other Healthcare Stocks? ResMed has significantly outperformed other healthcare stocks over the past year, and analysts remain bullish on the stock’s prospects.
Benzinga · Aug 1, 2025 ResMed Analysts Increase Their Forecasts After Strong Q2 Earnings Resmed Inc (NYSE:RMD) reported better-than-expected earnings for the second quarter on Thursday.
AAP · Aug 1, 2025 Global demand helps push ResMed shares to record high ResMed shares have hit an all-time high after the medical device-maker beat expectations on both revenue and profit.
Barchart · May 23, 2025 Are Wall Street Analysts Bullish on ResMed Stock? Although ResMed has outperformed the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects.
AAP · Apr 24, 2025 Solid earnings and tariff break awaken ResMed price While US President Donald Trump's tariffs have sent global markets into a tailspin, medical technology companies are well-positioned to weather the storm.
Barchart · Apr 14, 2025 Earnings Preview: What to Expect From ResMed’s Report ResMed is set to release its fiscal third-quarter earnings this month, with analysts forecasting a lower-double-digit growth in profits.
Barchart · Mar 20, 2025 Is ResMed Stock Outperforming the Dow? Despite ResMed’s outperformance relative to the Dow Jones over the past year, analysts are cautiously optimistic about the stock’s prospects.
Fortune · Mar 4, 2025 The global sleep crisis is costing companies. These 3 things are driving it. Globally, 71% of employed respondents have called in sick due to poor sleep at least once in their career.